{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T21:32:57Z","timestamp":1750109577288,"version":"3.37.3"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s13760-021-01612-6","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T21:02:28Z","timestamp":1617397348000},"page":"633-642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8775-0415","authenticated-orcid":false,"given":"Giuliana","family":"Galassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Marchioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"issue":"1","key":"1612_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/wnl.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55(1):16\u201323. https:\/\/doi.org\/10.1212\/wnl.55.1.16","journal-title":"Neurology"},{"key":"1612_CR2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/mus.26689","volume":"60","author":"RR Gummi","year":"2019","unstructured":"Gummi RR, Kukulka NA, Deroche CB et al (2019) Factors associated with acute exacerbations o myasthenia gravis. Muscle Nerve 60:693\u2013699. https:\/\/doi.org\/10.1002\/mus.26689","journal-title":"Muscle Nerve"},{"key":"1612_CR3","doi-asserted-by":"publisher","first-page":"e299","DOI":"10.1212\/WNL.0000000000008688","volume":"94","author":"B Neumann","year":"2020","unstructured":"Neumann B, Angstwurm K, Mergenthaler P et al (2020) Myasthenic crisis demanding mechanical ventilation: a multicenter analysis of 250 cases. Neurology 94:e299\u2013e313. https:\/\/doi.org\/10.1212\/WNL.0000000000008688","journal-title":"Neurology"},{"key":"1612_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/WCO.0000000000000596","volume":"31","author":"R Mantegazza","year":"2018","unstructured":"Mantegazza R, Bernasconi P, Cavalcante P (2018) Myasthenia gravis: from autoantibodies to therapy. Curr Opin Neurol 31:517\u2013525. https:\/\/doi.org\/10.1097\/WCO.0000000000000596","journal-title":"Curr Opin Neurol"},{"key":"1612_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/mus.23869","volume":"49","author":"A Leis","year":"2014","unstructured":"Leis A, Szatmary G, Ross MA et al (2014) West Nile virus infection and myasthenia gravis. Muscle Nerve 49:26\u201329. https:\/\/doi.org\/10.1002\/mus.23869","journal-title":"Muscle Nerve"},{"key":"1612_CR6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","volume":"263","author":"N Melzer","year":"2016","unstructured":"Melzer N, Ruck T, Gold R et al (2016) Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. J Neurol 263:1473\u20131494. https:\/\/doi.org\/10.1007\/s00415-016-8045-z","journal-title":"J Neurol"},{"key":"1612_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jemermed.2017.06.009","volume":"53","author":"J Roper","year":"2017","unstructured":"Roper J, Fleming ME, Long B et al (2017) Myasthenia gravis and crisis: evaluation and management in the emergency department. J Emerg Med 53:843\u2013853. https:\/\/doi.org\/10.1016\/j.jemermed.2017.06.009","journal-title":"J Emerg Med"},{"issue":"10223","key":"1612_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet 395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"China Lancet"},{"key":"1612_CR9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y et al (2020) Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 382:1708\u20131720. https:\/\/doi.org\/10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"1612_CR10","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W, Cao Y et al (2020) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130:2620\u20132629. https:\/\/doi.org\/10.1172\/JCI137244","journal-title":"J Clin Invest"},{"key":"1612_CR11","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China JAMA Intern Med 180:934\u2013943. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994","journal-title":"China JAMA Intern Med"},{"key":"1612_CR12","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.cmi.2020.04.012","volume":"26","author":"J Zhang","year":"2020","unstructured":"Zhang J, Wang X, Jia X et al (2020) Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan. China Clin Microbiol Infect 26:767\u2013772. https:\/\/doi.org\/10.1016\/j.cmi.2020.04.012","journal-title":"China Clin Microbiol Infect"},{"key":"1612_CR13","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa2001191","volume":"382","author":"ML Holshue","year":"2020","unstructured":"Holshue ML, DeBolt C, Lindquist S et al (2020) First case of 2019 Novel Coronavirus in the United States. N Engl J Med 382:929\u2013936. https:\/\/doi.org\/10.1056\/NEJMoa2001191","journal-title":"N Engl J Med"},{"key":"1612_CR14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","volume":"77","author":"L Mao","year":"2020","unstructured":"Mao L, Jin H, Wang M et al (2020) Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 77:683\u2013690. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1127","journal-title":"JAMA Neurol"},{"key":"1612_CR15","doi-asserted-by":"publisher","first-page":"116832","DOI":"10.1016\/j.jns.2020.116832","volume":"413","author":"AA Asadi-Pooya","year":"2020","unstructured":"Asadi-Pooya AA, Simani L (2020) Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci 413:116832. https:\/\/doi.org\/10.1016\/j.jns.2020.116832","journal-title":"J Neurol Sci"},{"key":"1612_CR16","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1111\/tbed.13594","volume":"67","author":"K Roe","year":"2020","unstructured":"Roe K (2020) Explanation for COVID-19 infection neurological damage and reactivations. Transbound Emerg Dis 67:1414\u20131415. https:\/\/doi.org\/10.1111\/tbed.13594","journal-title":"Transbound Emerg Dis"},{"key":"1612_CR17","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/jmv.25918","volume":"92","author":"HC Yashavantha Rao","year":"2020","unstructured":"Yashavantha Rao HC, Jayabaskaran C (2020) The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients. J Med Virol 92:786\u2013790. https:\/\/doi.org\/10.1002\/jmv.25918","journal-title":"J Med Virol"},{"key":"1612_CR18","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.4049\/jimmunol.1501339","volume":"196","author":"Y Cao","year":"2016","unstructured":"Cao Y, Amezquita RA, Kleinstein SH et al (2016) Autoreactive T cells from patients with myasthenia gravis are characterized by elevated IL-17, IFN-g, and GM-CSF and diminished IL-10 production. J Immunol 196:2075\u20132084. https:\/\/doi.org\/10.4049\/jimmunol.1501339","journal-title":"J Immunol"},{"issue":"3","key":"1612_CR19","doi-asserted-by":"publisher","first-page":"taaa041","DOI":"10.1093\/jtm\/taaa041","volume":"27","author":"JH Diaz","year":"2020","unstructured":"Diaz JH (2020) Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J Travel Med 27(3):taaa041. https:\/\/doi.org\/10.1093\/jtm\/taaa041","journal-title":"J Travel Med"},{"issue":"2","key":"1612_CR20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/mus.26918","volume":"62","author":"P Anand","year":"2020","unstructured":"Anand P, Slama MCC, Kaku M et al (2020) COVID-19 in patients with myasthenia gravis. Muscle Nerve 62(2):254\u2013258. https:\/\/doi.org\/10.1002\/mus.26918","journal-title":"Muscle Nerve"},{"key":"1612_CR21","doi-asserted-by":"publisher","first-page":"116888","DOI":"10.1016\/j.jns.2020.116888","volume":"414","author":"F Delly","year":"2020","unstructured":"Delly F, Syed MJ, Lisak RP et al (2020) Myasthenic crisis in COVID -19. J Neurol Sci 414:116888. https:\/\/doi.org\/10.1016\/j.jns.2020.116888","journal-title":"J Neurol Sci"},{"key":"1612_CR22","doi-asserted-by":"publisher","first-page":"576153","DOI":"10.3389\/fneur.2020.576153","volume":"11","author":"M Huber","year":"2020","unstructured":"Huber M, Rogozinski S, Puppe W et al (2020) Postinfectious onset of myasthenia gravis in a COVID-19 patient. Front Neurol 11:576153. https:\/\/doi.org\/10.3389\/fneur.2020.576153","journal-title":"Front Neurol"},{"key":"1612_CR23","doi-asserted-by":"publisher","first-page":"117053","DOI":"10.1016\/j.jns.2020.117053","volume":"417","author":"N Rein","year":"2020","unstructured":"Rein N, Haham N, Orenbuch-Harroch E et al (2020) Description of 3 patients with myasthenia gravis and COVID-19. J Neurol Sci 417:117053. https:\/\/doi.org\/10.1016\/j.jns.2020.117053","journal-title":"J Neurol Sci"},{"key":"1612_CR24","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1136\/jnnp-2020-323565","volume":"91","author":"A H\u00fcbers","year":"2020","unstructured":"H\u00fcbers A, Lascano AM, Lalive PH et al (2020) (2020) Management of patients with generalised myasthenia gravis and COVID-19: four case reports. J Neurol Neurosurg Psychiatry 91:1124\u20131125. https:\/\/doi.org\/10.1136\/jnnp-2020-323565","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1612_CR25","doi-asserted-by":"publisher","first-page":"106045","DOI":"10.1016\/j.clineuro.2020.106045","volume":"196","author":"S Singh","year":"2020","unstructured":"Singh S, Govindarajan R (2020) COVID-19 and generalized myasthenia gravis exacerbation: a case report. Clin Neurol Neurosurg 196:106045. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106045","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"1612_CR26","doi-asserted-by":"publisher","first-page":"E65","DOI":"10.1002\/mus.27020","volume":"62","author":"H Kushlaf","year":"2020","unstructured":"Kushlaf H (2020) COVID-19 in muscle-specific kinase myasthenia gravis: a case report. Muscle Nerve 62(4):E65\u2013E66. https:\/\/doi.org\/10.1002\/mus.27020","journal-title":"Muscle Nerve"},{"key":"1612_CR27","doi-asserted-by":"publisher","first-page":"L20","DOI":"10.7326\/L20-0845","volume":"10","author":"DA Restivo","year":"2020","unstructured":"Restivo DA, Centonze D, Alesina A et al (2020) Myasthenia gravis associated with SARS-CoV-2 infection. Ann Intern Med 10:L20-0845. https:\/\/doi.org\/10.7326\/L20-0845","journal-title":"Ann Intern Med"},{"key":"1612_CR28","doi-asserted-by":"publisher","first-page":"110001","DOI":"10.1016\/j.jclinane.2020.110001","volume":"67","author":"I Salik","year":"2020","unstructured":"Salik I, Rodhouse HB, Barst S (2020) Myasthenic crisis in the setting of Coronavirus Disease 2019 (COVID-19). J Clin Anesth 67:110001. https:\/\/doi.org\/10.1016\/j.jclinane.2020.110001","journal-title":"J Clin Anesth"},{"key":"1612_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3233\/JND-200520","volume":"7","author":"SB Ramaswamy","year":"2020","unstructured":"Ramaswamy SB, Govindarajan R (2020) COVID-19 in refractory myasthenia gravis- a case report of successful outcome. J Neuromuscul Dis 7:361\u2013364. https:\/\/doi.org\/10.3233\/JND-200520","journal-title":"J Neuromuscul Dis"},{"issue":"12","key":"1612_CR30","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1007\/s10072-020-04826-3","volume":"41","author":"G Scopelliti","year":"2020","unstructured":"Scopelliti G, Osio M, Arquati M et al (2020) Respiratory dysfunction as first presentation of myasthenia gravis misdiagnosed as COVID-19. Neurol Sci 41(12):3419\u20133421. https:\/\/doi.org\/10.1007\/s10072-020-04826-3","journal-title":"Neurol Sci"},{"key":"1612_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-020-10263-1","volume":"12","author":"S Sriwastava","year":"2020","unstructured":"Sriwastava S, Tandon M, Kataria S et al (2020) New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review. J Neurol 12:1\u20137. https:\/\/doi.org\/10.1007\/s00415-020-10263-1","journal-title":"J Neurol"},{"key":"1612_CR32","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3389\/fneur.2020.01053","volume":"11","author":"AE Camelo-Filho","year":"2020","unstructured":"Camelo-Filho AE, Silva AMS, Estephan EP et al (2020) Myasthenia Gravis and COVID-19: clinical characteristics and outcomes. Front Neurol 11:1053. https:\/\/doi.org\/10.3389\/fneur.2020.01053","journal-title":"Front Neurol"},{"key":"1612_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8845844","volume":"20","author":"E Aksoy","year":"2020","unstructured":"Aksoy E, Oztutgan T (2020) COVID-19 presentation in association with myasthenia gravis: a case report and review of the literature. Case Rep Infect Dis 20:1\u20134. https:\/\/doi.org\/10.1155\/2020\/8845844","journal-title":"Case Rep Infect Dis"},{"key":"1612_CR34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.5811\/cpcem.2020.9.49049","volume":"4","author":"P Moschella","year":"2020","unstructured":"Moschella P, Roth P (2020) Isolated COVID-19 infection precipitates myasthenia gravis crisis\u202f: a case report. Clin Pract Cases Emerg Med 4:524\u2013526. https:\/\/doi.org\/10.5811\/cpcem.2020.9.49049","journal-title":"Clin Pract Cases Emerg Med"},{"key":"1612_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00431-020-03841-y","volume":"13","author":"H G\u00fcne\u015f","year":"2020","unstructured":"G\u00fcne\u015f H, Din\u00e7er S, Ac\u0131payam C et al (2020) What chances do children have against COVID-19? Is the answer hidden within the thymus? Eur J Pediatr 13:1\u20134. https:\/\/doi.org\/10.1007\/s00431-020-03841-y","journal-title":"Eur J Pediatr"},{"issue":"7","key":"1612_CR36","doi-asserted-by":"publisher","first-page":"102556","DOI":"10.1016\/j.autrev.2020.102556","volume":"19","author":"G Lucchese","year":"2020","unstructured":"Lucchese G, Fl\u00f6el A  (2020) Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons. Autoimmun Rev 19(7):102556. https:\/\/doi.org\/10.1016\/j.autrev.2020.102556","journal-title":"Autoimmun Rev"},{"issue":"6","key":"1612_CR37","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/eji.200939792","volume":"40","author":"R Liu","year":"2010","unstructured":"Liu R, Zhou Q, La Cava A et al (2010) Expansion of regulatory T cells via IL-2\/anti-IL-2 mAb complexes suppresses experimental myasthenia. Eur J Immunol 40(6):1577\u20131589. https:\/\/doi.org\/10.1002\/eji.200939792","journal-title":"Eur J Immunol"},{"key":"1612_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","volume":"145","author":"M Thiruppathi","year":"2012","unstructured":"Thiruppathi M, Rowin J, Li Jiang Q et al (2012) Impaired regulatory function in circulating CD4(+) CD25(high) CD127(low\/-) T cells in patients with myasthenia gravis. Clin Immunol 145:209\u2013223. https:\/\/doi.org\/10.1016\/j.clim.2012.09.012","journal-title":"Clin Immunol"},{"key":"1612_CR39","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41423-020-0447-2","volume":"17","author":"W Wang","year":"2020","unstructured":"Wang W, Su B, Pang L et al (2020) High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients. Cell Mol Immunol 17:650\u2013652. https:\/\/doi.org\/10.1038\/s41423-020-0447-2","journal-title":"Cell Mol Immunol"},{"key":"1612_CR40","doi-asserted-by":"publisher","first-page":"S0006","DOI":"10.1016\/j.bbrc.2020.10.079","volume":"7","author":"B Kalfaoglu","year":"2020","unstructured":"Kalfaoglu B, Almeida-Santos J, Tye CA et al (2020) T-cell dysregulation in COVID-19. Biochem Biophys Res Commun 7:S0006. https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.079","journal-title":"Biochem Biophys Res Commun"},{"issue":"15","key":"1612_CR41","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"C Quin","year":"2020","unstructured":"Quin C, Zhou L, Hu Z et al (2020) Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan. China. Clin infect Dis 71(15):762\u2013768. https:\/\/doi.org\/10.1093\/cid\/ciaa248","journal-title":"China Clin infect Dis"},{"issue":"10","key":"1612_CR42","doi-asserted-by":"publisher","first-page":"852","DOI":"10.7326\/L20-0681","volume":"173","author":"DE Gladstone","year":"2020","unstructured":"Gladstone DE, Kim BS, Mooney K et al (2020) Regulatory T cells for treating patients with COVID-19 and acute respiratory distress syndrome: two case reports. Ann Intern Med 173(10):852\u2013853. https:\/\/doi.org\/10.7326\/L20-0681","journal-title":"Ann Intern Med"},{"key":"1612_CR43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cyto.2015.06.011","volume":"78","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hai-feng Li, Jiang B et al (2016) Elevated plasma interleukon-17A in a subgroup of Myasthenia Gravis patients. Cytokine 78:44\u201346. https:\/\/doi.org\/10.1016\/j.cyto.2015.06.011","journal-title":"Cytokine"},{"key":"1612_CR44","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.cyto.2017.05.008","volume":"96","author":"G Aguilo-Seara","year":"2017","unstructured":"Aguilo-Seara G, Xie Y, Sheehan J et al (2017) Ablation of IL-17 expression moderates experimental autoimmune myasthenia gravis disease severity. Cytokine 96:279\u2013285. https:\/\/doi.org\/10.1016\/j.cyto.2017.05.008","journal-title":"Cytokine"},{"key":"1612_CR45","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41577-020-0328-z","volume":"20","author":"O Pacha","year":"2020","unstructured":"Pacha O, Sallman MA, Evans SE et al (2020) COVID-19: a case for inhibiting IL-17? Nature reviews Immunol 20:345\u2013346. https:\/\/doi.org\/10.1038\/s41577-020-0328-z","journal-title":"Nature reviews Immunol"},{"key":"1612_CR46","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W et al (2020) (2020) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130:2620\u20132629. https:\/\/doi.org\/10.1172\/JCI137244","journal-title":"J Clin Invest"},{"key":"1612_CR47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1164\/rccm.201410-1782OC","volume":"193","author":"R Muir","year":"2016","unstructured":"Muir R, Osbourn M, Dubois AV et al (2016) Innate lymphoid cells are the predominant source of IL-17A during the early pathogenesis of acute respiratory distress syndrome. Am J Respir Crit Care Med 193:407\u2013416. https:\/\/doi.org\/10.1164\/rccm.201410-1782OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1612_CR48","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323:1061\u20131069. https:\/\/doi.org\/10.1001\/jama.2020.1585","journal-title":"JAMA"},{"key":"1612_CR49","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00134-020-06033-2","volume":"46","author":"L Gattinoni","year":"2020","unstructured":"Gattinoni L, Chiumello D, Caironi P et al (2020) COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 46:1099\u20131102. https:\/\/doi.org\/10.1007\/s00134-020-06033-2","journal-title":"Intensive Care Med"},{"issue":"12","key":"1612_CR50","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/S2213-2600(20)30370-2","volume":"8","author":"G Grasselli","year":"2020","unstructured":"Grasselli G, Tonetti T, Protti A et al (2020) Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med 8(12):1201\u20131208. https:\/\/doi.org\/10.1016\/S2213-2600(20)30370-2","journal-title":"Lancet Respir Med"},{"key":"1612_CR51","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/mus.10378","volume":"27","author":"I Heliopoulos","year":"2003","unstructured":"Heliopoulos I, Palakas G, Vadikolias K et al (2003) Maximal voluntary ventilation in myasthenia gravis. Muscle Nerve 27:715\u2013719. https:\/\/doi.org\/10.1002\/mus.10378","journal-title":"Muscle Nerve"},{"key":"1612_CR52","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/BF01711545","volume":"21","author":"P Rieder","year":"1995","unstructured":"Rieder P, Louis M, Jolliet P et al (1995) The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis. Intensive Care Med 21:663\u2013668. https:\/\/doi.org\/10.1007\/BF01711545","journal-title":"Intensive Care Med"},{"key":"1612_CR53","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1590\/0004-282X20130108","volume":"71","author":"DA Godoy","year":"2013","unstructured":"Godoy DA, Vaz de Mello LJ, Masotti L et al (2013) The myasthenic patient in crisis: an update of the management in neurointensive care unit. Arq Neuropsiquiatr 71:627\u2013639. https:\/\/doi.org\/10.1590\/0004-282X20130108","journal-title":"Arq Neuropsiquiatr"},{"key":"1612_CR54","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1055\/s-0036-1592106","volume":"36","author":"AA Lizarraga","year":"2016","unstructured":"Lizarraga AA, Lizarraga KJ, Benatar M (2016) Getting rid of weakness in the ICU: an updated approach to the acute management of myasthenia gravis and Guillain-Barr\u00e9 syndrome. Semin Neurol 36:615\u2013624. https:\/\/doi.org\/10.1055\/s-0036-1592106","journal-title":"Semin Neurol"},{"issue":"4","key":"1612_CR55","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1164\/rccm.166.4.518","volume":"166","author":"American Thoracic Society\/European Respiratory Society","year":"2002","unstructured":"American Thoracic Society\/European Respiratory Society (2002) ATS\/ERS Statement on respiratory muscle testing. Am J Respir crit Care Med 166(4):518\u2013624. https:\/\/doi.org\/10.1164\/rccm.166.4.518","journal-title":"Am J Respir crit Care Med"},{"key":"1612_CR56","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1152\/jappl.1982.53.5.1190","volume":"53","author":"F Bellemare","year":"1982","unstructured":"Bellemare F, Grassino A (1982) Effect of pressure and timing of contraction on human diaphragm fatigue. J Appl Physiol 53:1190\u20131195. https:\/\/doi.org\/10.1152\/jappl.1982.53.5.1190","journal-title":"J Appl Physiol"},{"key":"1612_CR57","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1164\/rccm.202005-1582LE","volume":"202","author":"P Esnault","year":"2020","unstructured":"Esnault P, Hraiech CMS, Cardinale M (2020) High respiratory drive and excessive respiratory efforts predict relapse of respiratory failure in critically ill patients with COVID-19. Am J Respir Crit Care Med 202:1173\u20131178. https:\/\/doi.org\/10.1164\/rccm.202005-1582LE","journal-title":"Am J Respir Crit Care Med"},{"key":"1612_CR58","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s00134-020-05942-6","volume":"46","author":"E Spinelli","year":"2020","unstructured":"Spinelli E, Mauri T, Beitler JR et al (2020) Respiratory drive in the acute respiratory distress syndrome: pathophysiology, monitoring, and therapeutic interventions. Intensive Care Med 46:606\u2013618. https:\/\/doi.org\/10.1007\/s00134-020-05942-6","journal-title":"Intensive Care Med"},{"issue":"7","key":"1612_CR59","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/thx.49.7.703","volume":"49","author":"F Garcia Rio","year":"1994","unstructured":"Garcia Rio F, Prados C, D\u00edez Tejedor E et al (1994) Breathing pattern and central ventilator drive in mild and moderate generalized myasthenia gravis. Thorax 49(7):703\u2013706. https:\/\/doi.org\/10.1136\/thx.49.7.703","journal-title":"Thorax"},{"key":"1612_CR60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.resp.2014.03.004","volume":"198","author":"F Laghi","year":"2014","unstructured":"Laghi F, Shaikh HS, Morales D et al (2014) Diaphragmatic neuromechanical coupling and mechanisms of hypercapnia during inspiratory loading. Respir Physiol Neurobiol 198:32\u201341. https:\/\/doi.org\/10.1016\/j.resp.2014.03.004","journal-title":"Respir Physiol Neurobiol"},{"key":"1612_CR61","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12931-020-01462-5","volume":"21","author":"S Dhont","year":"2020","unstructured":"Dhont S, Derom E, Van Braeckel E et al (2020) The pathophysiology of\u201dhappy\u201d hypoxemia in COVID-19. Respir Res 21:198. https:\/\/doi.org\/10.1186\/s12931-020-01462-5","journal-title":"Respir Res"},{"key":"1612_CR62","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1164\/rccm.202006-2157CP","volume":"202","author":"MJ Tobin","year":"2020","unstructured":"Tobin MJ, Laghi F, Jubran A (2020) Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med 202:356\u2013360. https:\/\/doi.org\/10.1164\/rccm.202006-2157CP","journal-title":"Am J Respir Crit Care Med"},{"key":"1612_CR63","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2009575","author":"DA Berlin","year":"2020","unstructured":"Berlin DA, Gulick RM, Martinez FJ (2020) Severe Covid-19. N Engl J Med 383:2451\u20132460.  https:\/\/doi.org\/10.1056\/NEJMcp2009575","journal-title":"N Engl J Med"},{"key":"1612_CR64","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s00134-020-06022-5","volume":"46","author":"W Alhazzani","year":"2020","unstructured":"Alhazzani W, Moller MH, Arabi YM et al (2020) Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med 46:854\u2013887. https:\/\/doi.org\/10.1007\/s00134-020-06022-5","journal-title":"Intensive Care Med"},{"key":"1612_CR65","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S2213-2600(20)30127-2","volume":"8","author":"MA Matthay","year":"2020","unstructured":"Matthay MA, Aldrich JM, Gotts JE (2020) Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir Med 8:433\u2013434. https:\/\/doi.org\/10.1016\/S2213-2600(20)30127-2","journal-title":"Lancet Respir Med"},{"key":"1612_CR66","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/mus.23445","volume":"46","author":"H Sakaguchi","year":"2012","unstructured":"Sakaguchi H, Yamashita S, Hirano T et al (2012) Myasthenic crisis patients who require intensive care unit management. Muscle Nerve 46:440\u2013442. https:\/\/doi.org\/10.1002\/mus.23445","journal-title":"Muscle Nerve"},{"key":"1612_CR67","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1097\/00003246-200212000-00009","volume":"30","author":"PN Varelas","year":"2002","unstructured":"Varelas PN, Chua HC, Natterman J et al (2002) Ventilatory care in myasthenia gravis crisis: assessing the baseline adverse event rate. Crit Care Med 30:2663\u20132668. https:\/\/doi.org\/10.1097\/00003246-200212000-00009","journal-title":"Crit Care Med"},{"key":"1612_CR68","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1385\/NCC:3:3:213","volume":"3","author":"AA Rabinstein","year":"2005","unstructured":"Rabinstein AA, Mueller-Kronast N et al (2005) Risk of estubation failure in patients with myasthenic crisis. Neurocrit Care 3:213\u2013215. https:\/\/doi.org\/10.1385\/NCC:3:3:213","journal-title":"Neurocrit Care"},{"key":"1612_CR69","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5)","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Yu Y, Xu J et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Res Med 8(5):475\u2013481. https:\/\/doi.org\/10.1016\/S2213-2600(20)30079-5","journal-title":"The Lancet Res Med"},{"key":"1612_CR70","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1183\/13993003.02130-2020","volume":"56","author":"C Franco","year":"2020","unstructured":"Franco C, Facciolongo N, Tonelli R et al (2020) Feasibility and clinical impact of out-of-ICU non-invasive respiratory support in patients with COVID-19 related pneumonia. Eur Respir J 56:2002130. https:\/\/doi.org\/10.1183\/13993003.02130-2020","journal-title":"Eur Respir J"},{"key":"1612_CR71","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02426-2016","author":"B Rochwerg","year":"2017","unstructured":"Rochwerg B, Brochard L, Elliott MW et al (2017) Official ERS\/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 50:1602426. https:\/\/doi.org\/10.1183\/13993003.02426-2016","journal-title":"Eur Respir J"},{"issue":"10","key":"1612_CR72","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1212\/01.wnl.0000033797.79530.16","volume":"59","author":"A Rabinstein","year":"2002","unstructured":"Rabinstein A, Wijdicks EF (2002) BiPAP in acute respiratory failure due to myasthenic crisis may prevent intubation. Neurology 59(10):1647\u20131649. https:\/\/doi.org\/10.1212\/01.wnl.0000033797.79530.16","journal-title":"Neurology"},{"key":"1612_CR73","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/archneurol.2007.1","volume":"65","author":"J Seneviratne","year":"2008","unstructured":"Seneviratne J, Mandrekar J, Wijdicks EF et al (2008) Noninvasive ventilation in myasthenic crisis. Arch Neurol 65:54\u201358. https:\/\/doi.org\/10.1001\/archneurol.2007.1","journal-title":"Arch Neurol"},{"issue":"12","key":"1612_CR74","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S1474-4422(20)30413-0","volume":"19","author":"S Muppidi","year":"2020","unstructured":"Muppidi S, Guptill JT, Jacob S et al (2020) COVID-19 associated risk and effects in myasthenia gravis (CARE-MG). Lancet Neurol 19(12):970\u2013971. https:\/\/doi.org\/10.1016\/S1474-4422(20)30413-0","journal-title":"Lancet Neurol"},{"key":"1612_CR75","doi-asserted-by":"publisher","first-page":"116803","DOI":"10.1016\/j.jns.2020.116803","volume":"412","author":"International MG\/COVID-19 Working Group;Jacob S , Muppidi S et al","year":"2020","unstructured":"International MG\/COVID-19 Working Group;Jacob S , Muppidi S et al (2020) Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci 412:116803. https:\/\/doi.org\/10.1016\/j.jns.2020.116803","journal-title":"J Neurol Sci"},{"issue":"18","key":"1612_CR76","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1212\/WNL.0000000000010651","volume":"95","author":"P Hoang","year":"2020","unstructured":"Hoang P, Hurtubise B, Muppidi S (2020) Clinical Reasoning\u202f: therapeutic considerations in myasthenic crisis due to COVID-19 infection. Neurology 95(18):840\u2013843. https:\/\/doi.org\/10.1212\/WNL.0000000000010651","journal-title":"Neurology"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-021-01612-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-021-01612-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-021-01612-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T04:12:06Z","timestamp":1622261526000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-021-01612-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1612"],"URL":"https:\/\/doi.org\/10.1007\/s13760-021-01612-6","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"type":"print","value":"0300-9009"},{"type":"electronic","value":"2240-2993"}],"subject":[],"published":{"date-parts":[[2021,4,2]]},"assertion":[{"value":"8 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}